• A Multicenter Prospective Observational Cohort Based on a Breast Cancer Medical Record Database in China

  NCT06591039

  RecruitingObservationalUpdated Sep 19, 2024
• The Characteristics, Treatment Patterns and Prognosis of Chinese Male Breast Cancer: A Real-world Study

  NCT06220630

  Unknown statusObservationalUpdated Jan 24, 2024
• A Nation-wide Multicenter Clinical Epidemiologic Study of Chinese Females With Advanced Breast

  NCT03047889

  Unknown statusObservationalUpdated Feb 9, 2017
• The Treatment Situation of Chinese County Population With Breast Cancer

  NCT05544123

  Unknown statusObservationalUpdated Jan 4, 2023
• Patient Report Outcome and Oncological Safety -Oncoplastic and Conventional BCS Cohort

  NCT05054777

  Unknown statusObservationalUpdated Sep 23, 2021
• Hong Kong Breast Cancer Study

  NCT02889458

  Active, not recruitingObservationalUpdated May 23, 2023

ClinicalTrials.gov ID

NCT04076111

Lead Sponsor

Fengxi SuOTHER

Overall Status

Unknown status

Study Type

Observational

Enrollment

20,000Estimated

Last Update Posted

Sep 3, 2019Actual

Start Date

Sep 5, 2019Estimated

Primary Completion Date

Dec 2025Estimated

Completion Date

Dec 2025Estimated

Official Title

Patterns of Breast Cancer Management and Prognosis of Breast Cancer in China：a Multicenter, Prospective, Real-world Cohort Study

Brief Summary

This is a multicenter, prospective, e, real-world cohort survey initiated by researchers to focus on the patterns of breast cancer management and prognosis of breast cancer in China, and to establish the multicenter, prospective breast cancer data platform. A total of 18 sites in Guangdong and Henan have cooperated to build a cooperative network unit. The sites will conduct prospective and standardized records concerning the clinical pathological features, treatment and prognosis of the early breast cancer patients who are treated in their own site each year, registering in the REDCap system.This real-world cohort study aims to provide a representative and reliable survey data of epidemiological characteristics, clinical treatment and prognosis of patients with early breast cancer in China and explore the establishment of a national multi-center breast cancer data platform model.

• Breast Cancer

Ages Eligible for Study

Child (0-17)Adult (18-64)Older Adult (65+)

Sexes Eligible for Study

All

Accepts Healthy Volunteers

No

Eligibility Criteria

Inclusion Criteria:

• Patients who are hospitalized and treated in a collaborative network unit
• Agree to enroll in the study and sign the informed consent form
• Histological diagnosis of ductal carcinoma in situ or invasive breast cancer
• Accept the Surgery-based surgical treatment
• Willing to cooperate with follow-up work

Exclusion Criteria:

• Previously Excisional biopsy (including minimally invasive resection) of the patient's breast
• Previously received neoadjuvant chemotherapy
• Imaging or histological evidence of distant metastasis

Observational Model

Cohort

Time Perspective

Cross-Sectional

Lead Sponsor

Fengxi SuOTHER

jiaodechuang@163.com